Source: MarketScreener

BB Biotech: Substantial pipeline progress at several portfolio companies offsets rate-related market volatility

(marketscreener.com) EQS-News: BB BIOTECH AG / Key word: Interim Report Substantial pipeline progress at several portfolio companies offsets rate-related market volatility 26.07.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as at July 26, 2024 Portfolio of BB Biotech AG as...https://www.marketscreener.com/quote/stock/BB-BIOTECH-AG-2975835/news/Substantial-pipeline-progress-at-several-portfolio-companies-offsets-rate-related-market-volatility-47476782/?utm_medium=RSS&utm_content=20240726

Read full article »
Annual Revenue
$100-500M
Employees
25-100
Rudy Le Blanc's photo - Managing Director of BB Biotech

Managing Director

Rudy Le Blanc

CEO Approval Rating

77/100

Read more